-
By John K. Waters
Nvidia announced a series of groundbreaking collaborations at the J.P. Morgan Healthcare Conference in San Francisco on Monday. These partnerships, spanning healthcare, life sciences, and biopharma, aim to accelerate the adoption and scalability of AI models across the sector, driving advancements in diagnostics, drug discovery, and precision medicine.
Read More
-
By John K. Waters
The U.S. Department of Health and Human Services (HHS) has unveiled its groundbreaking Artificial Intelligence Strategic Plan, a nearly 200-page framework designed to transform healthcare and human services through safe, ethical, and innovative applications of artificial intelligence.
Read More
-
By John K. Waters
ZEISS Medical Technology announced that its MEL 90 excimer laser has received approval from the U.S. Food and Drug Administration (FDA), granting it simultaneous approval for treating myopia, hyperopia, and mixed astigmatism. The FDA clearance positions the device as a versatile addition to the U.S. refractive surgery market, aiming to enhance patient outcomes and surgical efficiency.
Read More
-
By
From AI-powered mirrors to needle-free injections, the annual Consumer Electronics Show (CES), which drew thousands of attendees to Las Vegas last week, featured another crop of groundbreaking innovations.
Read More
-
By John K. Waters
Genomic sequencing company Illumina, announces a strategic collaboration with chipmaker NVIDIA to leverage artificial intelligence (AI) in accelerating the analysis of "multiomic" data, which the two companies say will revolutionize clinical research, genomics AI development, and drug discovery.
Read More
-
By John K. Waters
A new European Union framework for Health Technology Assessment (HTA) took effect on Sunday, promising to accelerate access to innovative medicines and medical devices for patients across the EU.
Read More
-
By John K. Waters
The Association for the Advancement of Medical Instrumentation (AAMI) has unveiled ANSI/AAMI EQ103:2024, which establishes minimum requirements for alternate equipment management programs in healthcare delivery organizations (HDOs).
Read More
-
By John K. Waters
The U.S. Food and Drug Administration (FDA) is proposing new guidelines for more effective use on a range of skin tones.
Read More
-
By John K. Waters
Medical device giant Stryker plans to acquire Inari Medical in an all-cash deal valued at $4.9 billion.
Read More
-
By John K. Waters
According to a recent report by global market research and consulting firm SNS Insider, the worldwide market for this technology is set to experience a seismic shift, projected to grow from $48.88 billion in 2023 to $199.21 billion by 2032, at a compound annual growth rate (CAGR) of 16.9 percent.
Read More
-
By John K. Waters
Healthcare providers across the United States may soon face new, stringent cybersecurity requirements under proposals from the U.S. Department of Health and Human Services (HHS), aimed at strengthening protections for sensitive patient data.
Read More
-
By John K. Waters
The American Telemedicine Association has launched the Center of Digital Excellence (CODE), a new initiative aimed at advancing digital health innovation by partnering with leading U.S. health systems and virtual care companies.
Read More
-
By John K. Waters
Nearly two-thirds of American adults believe it is very important to be notified when AI is used in their health care, a new study published in JAMA Network Open found, underscoring growing public concern about transparency in AI applications.
Read More
-
By John K. Waters
HeartBeam announces U.S. Food and Drug Administration clearance for its at-home, cable-free HeartBeam system for arrhythmia monitoring.
Read More
-
By John K. Waters
Zimmer Biomet announces U.S. FDA 510(k) clearance for its OsseoFit Stemless Shoulder System, an implant designed to preserve healthy bone during total shoulder replacement procedures.
Read More
-
By John K. Waters
Arizona State University (ASU) is launching a new doctoral training program developed to harness the power of AI to combat Alzheimer's disease, addressing a critical need for specialized researchers at the intersection of technology and healthcare.
Read More